Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Mcculloch currently holds 1,676,126 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Mcculloch has been a net seller of XERS stock. They have purchased $0 and sold $240.2K worth of shares.
Kevin Mcculloch's most recent insider trade was on Aug 3, 2026, when they sold 15,000 shares at $8.02 per share.
Kevin Mcculloch serves as Executive at Xeris Biopharma Holdings, Inc. (XERS). They have executed 7 insider transactions totaling $240.2K over their tenure at the company.
Kevin Mcculloch holds the position of Executive at Xeris Biopharma Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Kevin Mcculloch has shown a selling trading pattern, with $0 in total purchases and $240.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Mcculloch was on Aug 3, 2026, when they sold $120.2K worth of XERS shares. This transaction involved 15,000 shares at $8.02 per share.
Kevin Mcculloch currently owns 1,676,126 shares of Xeris Biopharma Holdings, Inc. (XERS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Mcculloch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Mcculloch has 7 Form 4 filings on record as an insider at Xeris Biopharma Holdings, Inc..
Set alerts for Kevin Mcculloch and 40,000+ other insiders.